Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families

@article{Hofmann2002DetectionOL,
  title={Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families},
  author={Wera Hofmann and Barbara Wappenschmidt and Simon Berhane and R. K. Schmutzler and Siegfried Scherneck},
  journal={Journal of Medical Genetics},
  year={2002},
  volume={39},
  pages={e36 - e36}
}
The breast and ovarian cancer susceptibility gene BRCA1 contains an unusually high density (41.5%) of Alu elements.1 The homology between these repetitive Alu sequences can promote ectopic or homotopic homologous recombination. Ectopic homologous recombination, such as that reported in the BRCA1 gene, leads to large genomic rearrangements, which subsequently may cause disease phenotypes. In the BRCA1 gene, a number of different Alu mediated rearrangements, ranging from 510 bp to 23.8 kb, have… 
MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early‐onset cases
TLDR
Advice is given for restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCa2MLPA screening only for families presenting with cooccurrence of female and male breast cancer.
Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi‐quantitative multiplex PCR method
TLDR
The results indicate that the semi‐quantitative multiplex PCR method is useful for the detection of large rearrangements in the BRCA1 gene and therefore represents an additional valuable tool for mutation analysis of BRC a1 and BRCa2.
Complete Mutation Screening and Haplotype Characterization of the BRCA1 Gene in 61 Familial Breast Cancer Patients from Norway
TLDR
Size variations analysis in the 5’UTR was repeated in a cohort of 159 unrelated familial breast/ovarian cancer patients and 94 healthy blood donors and association studies of the 5'UTR variations within the respective families were not conclusive.
Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
TLDR
The presence of BRCA large exon rearrangements in Asian populations should be investigated where clinical, diagnostic service is recommended and given the increasing number of rearrangement reported in recent years and their contribution to the B RCA mutation spectrum.
Mutation analysis of BRCA 1 and BRCA 2 genes in Iranian high risk breast cancer families
TLDR
The absence of BRCA1 mutations in the analysed families may suggest that penetrance or prevalence of BRA1 mutations may be lower in Iran, and whether both mutations are specific for the Iranian population or a special subgroup remains to be investigated in larger studies.
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
TLDR
It is revealed that LGRs comprise ~3% of identified BRCA1 mutations, a low rate in comparison to other populations, and some of the previously misunderstood rules of nomenclature are clarified, which will make uniform reporting of BRCa1/2 easier in the future.
A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2
TLDR
A novel diagnostic genetic test for the physical mapping of large rearrangements in BRCA1 and BRCa2 to be combined in clinical settings with an assay capable of detecting small mutations, based on molecular combing and FISH‐based technique for direct visualization of single DNA molecules at high resolution.
Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families
TLDR
The absence of BRCA1 mutations in the analysed families may suggest that penetrance or prevalence of BRA1 mutations may be lower in Iran, and whether both mutations are specific for the Iranian population or a special subgroup remains to be investigated in larger studies.
...
1
2
...

References

SHOWING 1-10 OF 20 REFERENCES
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
TLDR
It is reported that the currently available mutation spectrum of BRCA1 has been biased by PCR-based mutation-screening methods, such as SSCP, the protein truncation test (PTT) and direct sequencing, using genomic DMA as template.
Screening for GermLine Rearrangements and Regulatory Mutations in BRCA 1 Led to the Identification of Four New Deletions 1
TLDR
A series of 27 American and 51 French breast cancer families in which no BRCA1 mutation was identified by classical techniques were analyzed, and four families were found to carry distinct deletions, suggesting the search for rearrangements appears mandatory in mutation screening studies.
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families
TLDR
This work studied 60 affected probands belonging to families with a strong history of breast and/or ovarian cancer who scored negative for BRCA1 gene mutations by PTT and SSCP analysis and identified a 3 kb deletion encompassing exon 17 and causing a frameshift mutation.
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
TLDR
To identify possible features of the BRCA1 genomic region that may contribute to chromosomal instability as well as potential transcriptional regulatory elements, a 117,143-bp DNA sequence encompassing BRC a1 was obtained by random sequencing of four cosmids identified from a human chromosome 17 specific library.
The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.
TLDR
The results demonstrate that it is strongly advisable, for laboratories carrying out screening either in English-speaking countries or in countries with historical links with Britain, to include within their BRCA1 screening protocols the polymerase chain reaction-based assay described in this report.
An Alu‐mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10
TLDR
It is suggested that the two American families who carry this deletion are of northern European ancestry and share a common haplotype, suggesting that this deletion may represent a founder mutation.
Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer
TLDR
A Long PCR strategy for screening the entire genomic BRCA1 locus in high‐risk families in which no genomic mutations had been detected using conventional methods revealed a complex mutation, g.12977 ins10 del1039, which was not detected among 11 other breast cancer families, nor among 406 breast cancer patients unselected for family history.
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
  • A. Meindl
  • Biology
    International journal of cancer
  • 2002
TLDR
The main focus of this German‐wide multi‐center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes and to provide strong evidence for further predisposing genes in the German population.
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
TLDR
Re rearrangements in the BRCA1 gene should be sought in breast/ovarian cancer families in which no mutations have been found by PCR-based methods in the coding region or in the splice sites.
Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
TLDR
The prior probability of detecting a BRCA1 mutation may be a useful predictor when considering the use of Southern blot analysis for families with breast/ovarian cancer who do not have detectable coding-region mutations.
...
1
2
...